Latest Innovation News

Page 344 of 366
Optiscan Imaging Ltd has secured a $1.775 million R&D tax refund for FY24, more than doubling last year’s amount thanks to expanded claims on overseas research. The boost will fund ongoing development of its cutting-edge confocal laser endomicroscopy technology.
Ada Torres
Ada Torres
31 Jan 2025
BirdDog Technology reports a strategic pivot with four next-generation product launches, a 20% price increase, and a robust cash position, despite a 13% revenue decline in H1 FY25.
Sophie Babbage
Sophie Babbage
31 Jan 2025
Vitrafy Life Sciences reports strong Q2 FY2025 progress, marked by a successful $35 million IPO, promising validation results in animal and human health, and strategic expansion into North America.
Victor Sage
Victor Sage
31 Jan 2025
ResMed Inc. posted a robust second quarter for fiscal year 2025, with revenue climbing 10% to $1.3 billion and operating profit soaring 52%, driven by strong demand for sleep and breathing health products and operational efficiencies.
Ada Torres
Ada Torres
31 Jan 2025
Weebit Nano has solidified its position in the semiconductor memory sector by signing a major licensing agreement with onsemi and raising A$50 million in capital. The company is well-funded and advancing multiple commercial and technical milestones.
Sophie Babbage
Sophie Babbage
31 Jan 2025
Volt Group Limited reported a robust 20% increase in FY24 revenue receipts, driven by strong EcoQuip growth and strategic contract wins, while advancing its zero-emission ATEN technology with promising trials underway.
Sophie Babbage
Sophie Babbage
31 Jan 2025
Carnegie Clean Energy has secured significant funding and made key progress in its ACHIEVE Programme, setting the stage for CETO wave energy deployment in the Basque Country in 2025.
Victor Sage
Victor Sage
31 Jan 2025
Titomic Limited has secured AUD 30 million in equity funding and appointed new leadership as it establishes a U.S. headquarters in Huntsville, Alabama, aiming to capitalize on growing aerospace and defense demand.
Victor Sage
Victor Sage
31 Jan 2025
Paradigm Biopharmaceuticals has appointed Advanced Clinical as the Clinical Research Organisation for its critical Phase 3 trial targeting knee osteoarthritis pain, setting the stage for patient recruitment and dosing in Q2 2025.
Ada Torres
Ada Torres
31 Jan 2025
First Graphene Limited reports a robust December quarter with new patents, expanded distribution networks, and advancing commercial trials, positioning the company on a path to cash breakeven.
Victor Sage
Victor Sage
31 Jan 2025
Adisyn Ltd has completed its transformative acquisition of 2D Generation, securing a $10 million capital raise to accelerate development of graphene-enhanced semiconductor technologies. The company is positioning itself to disrupt key markets including defence, data centres, and cybersecurity.
Sophie Babbage
Sophie Babbage
31 Jan 2025
TrivarX has solidified its regulatory strategy for the pivotal MEB-001 trial with the FDA and unveiled a new algorithm that expands its mental health screening reach beyond sleep clinics.
Ada Torres
Ada Torres
31 Jan 2025